Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-04-30

FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (ScieGen Pharmaceuticals Inc)

View source ↗

Summary

The FDA approved a supplemental application for hydrochlorothiazide submitted by ScieGen Pharmaceuticals Inc., endorsing changes to the product under an approve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROCHLOROTHIAZIDE (hydrochlorothiazide)

Snippet

SUPPL AP for HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE)